Maia Biotechnology, Inc.
SEC CIK 1878313 · MAIA · last insider filing 2026-06-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Smith Stan | Director | filed 2022 - 2026 |
| Vitoc Vlad | Director · Chief Executive Officer | filed 2022 - 2026 |
| Chaouki Steven M | Director | filed 2022 - 2026 |
| Guerrero Ramiro | Director | filed 2022 - 2026 |
| Louie Ngar Yee | Director | filed 2022 - 2026 |
| Luput Cristian | Director | filed 2022 - 2026 |
| Theagene Jean-Manasse | Director | filed 2023 - 2026 |
| Vlad Laurentiu | Director | filed 2022 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Gryaznov Sergei | Chief Scientific Officer | filed 2022 - 2026 |
| Himmelreich Jeffrey C | Head of Finance | filed 2023 - 2026 |
| Mcguire Joseph F | Chief Financial Officer | filed 2022 - 2023 |
| Obrocea Mihail | Chief Medical Officer | filed 2022 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.